259 filings
Page 4 of 13
8-K
qfrsxpyrhzi rruo5bj
23 Aug 21
Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Dr. Christopher Kenney as Chief Medical Officer
8:33am
8-K
ui1ugxiw5g rdh5
11 Aug 21
Xenon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:16pm
8-K
802e7rqclawgim
3 Jun 21
Submission of Matters to a Vote of Security Holders
5:25pm
8-K
k5vu29mkzls 4f5
11 May 21
Xenon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:17pm
8-K
4g6j5
12 Mar 21
Departure of Directors or Certain Officers
5:03pm
424B5
uty6mgr
10 Mar 21
Prospectus supplement for primary offering
5:26pm
8-K
ebn3q7xbaa
10 Mar 21
Other Events
5:24pm
424B5
ww5tx
9 Mar 21
Prospectus supplement for primary offering
5:26pm
8-K
zr0fu x9ipbc
1 Mar 21
Xenon Pharmaceuticals Reports 2020 Financial Results and Provides Corporate Update
4:04pm
8-K/A
7898b 1lai
14 Jan 21
Departure of Directors or Certain Officers
8:09am
8-K
jinnk161ixnopq0
14 Jan 21
Topline Data from XEN1101 Phase 2b X-TOLE Clinical Trial in Adult Focal Epilepsy on Track for Third Quarter of 2021
8:05am
8-K
hcmt703 q2c4tfb6
5 Nov 20
Xenon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:11pm
CT ORDER
qrocie6xise93dzwi5u
1 Sep 20
Confidential treatment order
9:33am
8-K
hrrvef u8z8w9o147x0
17 Aug 20
Xenon Pharmaceuticals Appoints Dr. Chris Von Seggern as Chief Commercial Officer
8:34am
424B5
4cel6 j5g3287lovg
6 Aug 20
Prospectus supplement for primary offering
5:17pm